Compounds > 2',3'-dideoxy-beta-5-fluorocytidine
Page last updated: 2024-08-25

2',3'-dideoxy-beta-5-fluorocytidine and Hepatitis B Virus Infection

2',3'-dideoxy-beta-5-fluorocytidine has been researched along with Hepatitis B Virus Infection in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, YC; Dutschman, GE; Lin, TS; Liu, MC; Luo, MZ; Pai, SB1

Other Studies

1 other study(ies) available for 2',3'-dideoxy-beta-5-fluorocytidine and Hepatitis B Virus Infection

ArticleYear
Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro.
    Biochemical pharmacology, 1994, Jan-20, Volume: 47, Issue:2

    Topics: Antiviral Agents; Cells, Cultured; DNA; Hepatitis B; Hepatitis B virus; HIV-1; Stereoisomerism; Virus Replication; Zalcitabine

1994